V+PSF-M for Tobacco Cessation in HIV Care in India (NCT05786547)
Varenicline and Mobile Behavioral Assistance for Tobacco Cessation in HIV Care in India
🩺 Plain-English Summary (8th-Grade Level)
The goal of this research study is to test an intervention to help quit tobacco use in participants with Human Immunodeficiency Virus (HIV). The study interventions used in this research study are: * Positively Smoke Free - Mobile (PSF-M) (mobile behavioral program) * Varenicline (or Chantix, apovarenicline, Champix or Nocrav)
Who can join: Review the eligibility criteria below.
Location: University of Colorado — Aurora, Colorado
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (2 Sites)
- University of Colorado — Aurora, Colorado
- VHS Infectious Disease Medical Centre, CART Clinical Research Site — Chennai, Tamil Nadu
📞 Contact the Study Coordinator
Phone: (303) 724-4811
Email: gina.kruse@cuanschutz.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Human Immunodeficiency Virus
- Anal High-risk HPV, HSIL, and Microbiome Among Hispanic Peoples Living With HIV (PLWH) — San Francisco, California
- Harm Reduction in HIV Primary Care for PLWH Who Use Drugs — Birmingham, Alabama
- Cross-disciplinary HIV Integrated Mental Health Support Intervention — Atlanta, Georgia
- Medical Mistrust Among Hispanic/Latino Gay, Bisexual and Other Men Who Have Sex With Men (HLMSM) — Winston-Salem, North Carolina
- Lenacapavir Intensification to Disrupt HIV Reservoirs in Virologically Suppressed People With HIV Receiving Antiretroviral Therapy — Bethesda, Maryland
- Baricitinib for Reduction of HIV - CNS — Atlanta, Georgia
Explore by condition: All Human Immunodeficiency Virus clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.